1 / 7

Pain Management Drugs Market Size Development Trends, Competitive Landscape

Global Market Insights Inc. adds Global Pain Management Drugs Market Report focuses on the major drivers and restraints for the Global key players. It also provides analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.

energy010
Download Presentation

Pain Management Drugs Market Size Development Trends, Competitive Landscape

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pain Management Drugs Market Analysis & Forecast to 2032 by Key Players, Share, Trend, Segmentation

  2. Industry Insights • The scaling R&D investments by pharmaceutical companies for creating novel pain management drugs and formulations for enhanced efficacy and reduced side effects will drive the industry growth. • To cite an instance, in July 2023, EuroAPI's controlled substance unit Francopia invested $76 million in a project for boosting the production of pain relief active pharmaceutical ingredients at its plant in Vertolaye, France. • The growing innovations in drug delivery systems to improve the effectiveness as well as safety of pain medications will also influence the product demand. • In terms of indication, the pain management drugs industry from the arthritic pain segment may record appreciable CAGR from 2023-2032. This is due to the rising need to alleviate and eliminate pain associated with arthritis.

  3. According to the Office of Disease Prevention and Health Promotion, the number of arthritis-affected adults is projected to rise to 78.4 million by 2040. • Hence, the increasing usage of pain management drugs for arthritic pain to limit the discomfort and enhance the quality of life will add to the market growth. • On the basis of distribution channel, the market value from the online pharmacies segment is expected to expand up to 2032. • The growth can be attributed to the growing preference for online pharmacies as they offer convenience, accessibility, and wide range of pain relief medications to consumers seeking relief from several types of pain. • The increasing integration with telemedicine services to enable patients to consult with healthcare providers online as well as receive prescriptions will also contribute to the segment expansion.

  4. Regional Analysis • Regionally, APAC pain management drugs market size is projected to record notable CAGR through 2032 due to the rising emphasis on patient-centric care and higher technological advancements, such as neuromodulation techniques. Increasing improvements in healthcare infrastructure as well as access to medical services has led to better diagnosis and treatment of pain conditions in the region, further driving the preference for pain management drugs. • Competitive Analysis • The prominent players are ENDO HEALTH SOLUTIONS, INC. (ENDO INTERNATIONAL PLC.), Merck & Co., Inc., Novartis AG Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Abbott Laboratories, Purdue Pharma L.P., GlaxoSmithKline Plc., Johnson & Johnson, and F. Hoffmann La Roche Ltd.

  5. Pain Management Drugs Market @ https://www.gminsights.com/industry-analysis/pain-management-drugs-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/6231 Request for customization @ https://www.gminsights.com/roc/6231

  6. Stay In Touch Social Media:

  7. THANK YOU www.gminsights.com

More Related